Rob Gons: Nothing to disclose
Compounding Semaglutide at home can be risky due to potential issues like lower bioavailability, incorrect dosing, and the use of inappropriate substances which may not have the same therapeutic effects
Compounds with no prescription channel need replacing with supervised tools aimed at the same goal
Batch number: Listed on product packaging or vial label COA access: Available through the product page and at Secra Labs Lab Results & COAs Verification purpose: Confirms product identity and analytical testing data for the listed batch Storage & Handling Long-term storage: Store lyophilized material at -20C when possible Short-term storage: 2-8C may be suitable before laboratory use Handling: Handle only in a controlled laboratory setting using appropriate laboratory procedures Protection: Keep sealed and protected from excess heat, moisture, and direct light This product should only be handled by trained personnel familiar with laboratory safety practices and institutional handling requirements for research materials
Laboratory animals were housed in polycarbonate (PC) cages under conventional laboratory conditions at 2024C, relative humidity of 4070%, and noise level of 60 dB
At 2.4 mg weekly, average weight loss reached about 15% over 68 weeks. Response varied widely: 86% lost at least 5%, 69% lost 10%, half lost 15%, and about one-third lost 20%. These results describe that cohort rather than a universal forecast
